Publications
Powell WE, Hanna SJ, Hocter CN, Robinson E, Lewis M, Dunseath G, Luzio S, Howell A, Dayan CM, Wong FS. Detecting autoreactive B cells in the peripheral blood of people with type 1 diabetes using ELISpot. J Immunol Methods. 2019 Aug;471:61-65. doi: 10.1016/j.jim.2019.05.007. Epub 2019 May 29. PMID: 31152768
Min T, Prior SL, Churm R, Dunseath G, Barry JD, Stephens JW. Effect of Laparoscopic Sleeve Gastrectomy on Static and Dynamic Measures of Glucose Homeostasis and Incretin Hormone Response 4-Years Post-Operatively. Obes Surg. 2019 Aug 3. doi: 10.1007/s11695-019-04116-8. [Epub ahead of print]. PMID: 31377992
Bain SC, Bekker Hansen B, Hunt B, Chubb B, Valentine WJ. Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK. J Med Econ. 2019 Aug 2:1-8. doi: 10.1080/13696998.2019.1645018. [Epub ahead of print]. PMID: 31311364
Moser O, Eckstein ML, McCarthy O, Deere R, Pitt J, Williams DM, Hayes J, Sourij H, Bain SC, Bracken RM. Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial. Diabetes Obes Metab. 2019 Jul 23. doi: 10.1111/dom.13835. [Epub ahead of print]. PMID: 31332929
Ali A, Bain S, Hicks D, Newland Jones P, Patel DC, Evans M, Fernando K, James J, Milne N, Viljoen A, Wilding J; As part of The Improving Diabetes Steering Committee. Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice. Diabetes Ther. 2019 Jul 18. doi: 10.1007/s13300-019-0670-y. [Epub ahead of print]. PMID: 31321747
McCarthy O, Moser O, Eckstein ML, Bain SC, Pitt J, Bracken R. Supplementary Nitric Oxide Donors and Exercise as Potential Means to Improve Vascular Health in People with Type 1 Diabetes: Yes to NO?. Nutrients. 2019 Jul 12;11(7). pii: E1571. doi: 10.3390/nu11071571. Review. PMID: 31336832
Ali A, Bain S, Hicks D, Newland Jones P, Patel DC, Evans M, Fernando K, James J, Milne N, Viljoen A, Wilding J; As part of The Improving Diabetes Steering Committee. SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice. Diabetes Ther. 2019 Jul 9. doi: 10.1007/s13300-019-0657-8. [Epub ahead of print] Review. Erratum in: Diabetes Ther. 2019 Jul 18;:. PMID: 31290126
Dunseath GJ, Bright D, Jones C, Dowrick S, Cheung WY, Luzio SD. Performance evaluation of a self-administered home oral glucose tolerance test kit in a controlled clinical research setting. Diabet Med. 2019 Jul;36(7):862-867. doi: 10.1111/dme.13961. Epub 2019 Apr 26. PMID: 30972793. Read lay summary here
Tack CJ, Jacob S, Desouza C, Bain SC, Buse JB, Nauck MA, Petrie JR, Poulter NR, Pratley RE, Stegmann HVBK, Bosch-Traberg H, Startseva E, Zinman B; LEADER Publication Committee on behalf of the LEADER Trial Investigators. Long-term efficacy and safety of combined insulin and glucagon-like peptide-1 therapy: Evidence from the LEADER trial. Diabetes Obes Metab. 2019 Jul 7. doi: 10.1111/dom.13826. [Epub ahead of print]. PMID: 31282028
Ibanez-Bruron MC, Solebo AL, Cumberland PM, Rahi JS; Diabetic Eye Disease in Childhood Study (DECS) group. Vulnerabilities in diabetic eye screening for children and young people in England. Pediatr Diabetes. 2019 Jul 3. doi: 10.1111/pedi.12887. [Epub ahead of print]. PMID: 31270908